This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.

Condition
Acquired Immunodeficiency Syndrome Neoplasm Skin Disease HIV Infections

Further Study Details: 

Expected Total Enrollment:  9999

This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.

Genders Eligible for Study:  Both

Criteria

INCLUSION CRITERIA:
Eligible patients include those who have been previously enrolled on an approved NCI research protocol.
A CCR investigator decides that it is in the best interests of the patient and the NCI for the patient to be enrolled on this protocol and continue to receive care and follow-up at the NIH.
The patient or guardian signs the consent.

Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike,  Bethesda,  Maryland,  20892,  United States; Recruiting

Study ID Numbers:  920094; 92-C-0094
Record last reviewed:  October 1, 2004
Last Updated:  November 23, 2004
Record first received:  November 3, 1999
ClinicalTrials.gov Identifier:  NCT00001295
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08